MedDataX Logo

Walking Aids in the Management of Hip Osteoarthritis

NCT ID: NCT00506714

Last Updated: 2012-10-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-07-31

Study Completion Date

2009-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether or not the use of a nonpharmacologic intervention (single point cane) is effective in the treatment of knee osteoarthritis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Osteoarthritis (OA), the most common joint disease in humans, is a significant cause of pain and disability. Non-pharmacological treatments for hip OA include education, exercise, appliances (walking sticks or insoles), and weight reduction if obese or overweight. Canes are often recommended to reduce adverse forces across joints although there is currently no research evidence regarding the efficacy of walking sticks for hip OA. Little information is available regarding the impact of walking aids on psychosocial function and quality of life in individuals with hip OA. This study will evaluate the effects of walking aids in hip OA by examining gait biomechanics, quality of life, pain, and opinions regarding using a cane.

Comparisons: Compare gait biomechanics in people with symptomatic unilateral hip OA while walking with and without a cane at baseline and after 4 weeks of cane use. Compare gait biomechanics in people with symptomatic unilateral hip OA with and without a cane to those of healthy, age-matched controls. Compare pain and health-related quality of life in people with symptomatic unilateral hip OA following 4 weeks of cane use. Determine the association between changes in gait biomechanics, pain, and health-related quality of life in people with symptomatic unilateral hip OA following 4 weeks of cane use.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Osteoarthritis Walking Sticks Canes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adult subjects with hip osteoarthritis

Walk with and without a single point cane at baseline and after four weeks

Group Type EXPERIMENTAL

single point cane

Intervention Type DEVICE

Adjustable single point cane with SureGrip handle

Healthy Subjects

Healthy adults walking without a cane at baseline

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

single point cane

Adjustable single point cane with SureGrip handle

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. hip OA (grades II-IV) of the Kellgren/Lawrence classification
2. with pain in one hip for most days of the prior month
3. Ability to walk 30 feet without postural sway
4. Ability to stand unaided
5. Ability to understand verbal instructions
6. Ability to give informed consent

Exclusion Criteria

1. History of hip or knee trauma or surgery including arthroscopic surgery in the past six months
2. Severe obesity (\> 300 pounds)
3. Neurological disorders that affect lower extremity function such as stroke or peripheral neuropathy, vestibular dysfunction or poor vision
4. Injury or amputation to the lower extremity joints
5. History of other types of arthritis or fibromyalgia
6. Pain from spine, knee, ankle, or foot disease that would interfere with assessment of the hip
7. Poor health that would impair compliance or assessment such as shortness of breath with exertion, chest pain
8. Foot deformities such as hallux rigidus, valgus deformity of the midfoot, previous ankle arthrodesis
9. Greater trochanteric pain syndrome
Minimum Eligible Age

60 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Arthritis Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Meika A. Fang, MD

Rheumatology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Meika A Fang, MD

Role: PRINCIPAL_INVESTIGATOR

VA Greater Los Angeles Healthcare System Department of Medicine; UCLA Department of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

VA West Los Angeles

Los Angeles, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2007-030430

Identifier Type: -

Identifier Source: org_study_id